BackChina Biotech Services Holdings Limited Overview

China Biotech Services Holdings Limited Receivables

China Biotech Services Holdings Limited's receivables is $28M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$27.52M
↑ 69.24% YoYΔ $11.26M vs prior year quarter

Peer trimmed avg / median

Loading

China Biotech Services Holdings Limited Receivables History

Loading

China Biotech Services Holdings Limited vs. peers: Receivables Comparison

Loading

China Biotech Services Holdings Limited Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

China Biotech Services Holdings Limited (8037.HK) FAQ

The latest receivables for 8037.HK is $28M as of June 2026. That compares with $16M in the prior-year period — up 69.2% year over year. Investors often review this figure alongside China Biotech Services Holdings Limited's historical trend and sector peers before judging valuation or financial health.

Over the past year, 8037.HK's receivables moved from $16M to $28M — a 69.2% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in China Biotech Services Holdings Limited's operating scale or balance-sheet position.

A receivables figure of $28M for 8037.HK is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting 8037.HK's receivables ($28M), review year-over-year change from $16M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.